awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31106171-F328DCA4-C937-4F0B-9C45-161D06CEC1C6
Q31106171-F328DCA4-C937-4F0B-9C45-161D06CEC1C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31106171-F328DCA4-C937-4F0B-9C45-161D06CEC1C6
Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study
P2860
Q31106171-F328DCA4-C937-4F0B-9C45-161D06CEC1C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31106171-F328DCA4-C937-4F0B-9C45-161D06CEC1C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9679e046e1338089c5cba7fb2438164e8c8cb110
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.